A Double-blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (perampanel) Given as Adjunctive Therapy in Subjects with Refractory Partial Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/08 → 10/31/12

Funding

  • Eisai Incorporated: $48,791.00